Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer
Go back to Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 2,394,190 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 2,394,190 | |||||
| Daiichi Sankyo Co Limited Sponsored ADR (AMEX: DSNKY) | Delayed: 15.80 -0.06 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.86 | 52 Week High | $26.24 | |||
| Open | $15.67 | 52 Week Low | $18.86 | |||
| Day High | $15.99 | P/E | N/A | |||
| Day Low | $15.63 | EPS | $0.00 | |||
| Volume | 199,781 | |||||
